Rigel Pharmaceuticals, Inc. (RIGL) SEC filings
RIGL SEC filings moved a median of -0.82% by the close. RIGL SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the RIGL overview →
60 measured RIGL SEC filing events.
Where these RIGL SEC filings landedvs 60 measured RIGL SEC filing reactions
| Middle 50% of RIGL SEC filing reactions | -5.02% to +2.96% |
|---|---|
| Median reaction (to close) | -0.82% |
| Measured reactions | 60 |
Point-in-time · zero look-ahead
Half of the 60 RIGL SEC filing events with a measured close landed between -5.02% and +2.96%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q RIGEL PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -1.63% | -4.71% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Aug 04 | SEC filing · Form 8-K | -1.63% | -4.71% | |
| Form S-8 RIGEL PHARMACEUTICALS | SEC filing · Form S-8 | -1.63% | -4.71% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Jun 25 | SEC filing · Form 8-K | +0.61% | -1.17% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Jun 11 | SEC filing · Form 8-K | -0.68% | -3.18% | |
| Form 8-K RIGEL PHARMACEUTICALS For: May 14 | SEC filing · Form 8-K | +0.14% | +3.22% | |
| Form 8-K RIGEL PHARMACEUTICALS For: May 11 | SEC filing · Form 8-K | +3.57% | +6.32% | |
| Form 10-Q RIGEL PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -2.44% | -7.07% | |
| Form 8-K RIGEL PHARMACEUTICALS For: May 05 | SEC filing · Form 8-K | -2.44% | -7.07% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Apr 16 | SEC filing · Form 8-K | -0.22% | -6.10% | |
| Form DEF 14A RIGEL PHARMACEUTICALS For: May 14 | SEC filing · Form DEF | -0.16% | -0.80% | |
| Form DEFA14A RIGEL PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.16% | -0.80% | |
| Form 10-K RIGEL PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -5.12% | -2.15% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Mar 03 | SEC filing · Form 8-K | -5.12% | -2.15% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Feb 01 | SEC filing · Form 8-K | +0.34% | -2.56% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Jan 12 | SEC filing · Form 8-K | -3.22% | -4.08% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Dec 07 | SEC filing · Form 8-K | +0.56% | +2.69% | |
| Form 10-Q RIGEL PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +3.56% | +8.55% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Nov 04 | SEC filing · Form 8-K | +3.56% | +8.55% | |
| Form S-8 RIGEL PHARMACEUTICALS | SEC filing · Form S-8 | -2.54% | +9.68% | |
| Form 10-Q RIGEL PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -2.54% | +9.68% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Aug 05 | SEC filing · Form 8-K | -2.54% | +9.68% | |
| Form 8-K RIGEL PHARMACEUTICALS For: May 22 | SEC filing · Form 8-K | -0.21% | +2.29% | |
| Form 10-Q RIGEL PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.89% | -18.09% | |
| Form 8-K RIGEL PHARMACEUTICALS For: May 06 | SEC filing · Form 8-K | +0.89% | -18.09% | |
| Form ARS RIGEL PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | -0.99% | +2.96% | |
| Form DEF 14A RIGEL PHARMACEUTICALS For: May 22 | SEC filing · Form DEF | -0.99% | +2.96% | |
| Form DEFA14A RIGEL PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.99% | +2.96% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Mar 27 | SEC filing · Form 8-K | +0.93% | -5.50% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Mar 06 | SEC filing · Form 8-K | -3.59% | -0.10% | |
| Form 10-K RIGEL PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -0.74% | +0.69% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Mar 04 | SEC filing · Form 8-K | -0.74% | +0.69% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Jan 13 | SEC filing · Form 8-K | -5.67% | -4.04% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Dec 09 | SEC filing · Form 8-K | +2.41% | -8.09% | |
| Form 10-Q RIGEL PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +11.50% | +32.55% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Nov 07 | SEC filing · Form 8-K | +11.50% | +32.55% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Sep 16 | SEC filing · Form 8-K | +0.00% | +0.88% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Sep 03 | SEC filing · Form 8-K | -1.39% | -1.21% | |
| Form EFFECT RIGEL PHARMACEUTICALS | SEC filing · Form EFFECT | +1.55% | +9.33% | |
| Form 10-Q RIGEL PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +2.10% | -6.00% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Aug 06 | SEC filing · Form 8-K | +2.10% | -6.00% | |
| Form S-8 RIGEL PHARMACEUTICALS | SEC filing · Form S-8 | +2.10% | -6.00% | |
| Form S-3 RIGEL PHARMACEUTICALS | SEC filing · Form S-3 | -4.11% | -4.87% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Jun 27 | SEC filing · Form 8-K | +2.26% | -11.52% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Jun 25 | SEC filing · Form 8-K | -10.51% | -6.37% | |
| Form 8-K RIGEL PHARMACEUTICALS For: May 24 | SEC filing · Form 8-K | +1.08% | +0.83% | |
| Form 10-Q RIGEL PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -5.41% | -10.60% | |
| Form 8-K RIGEL PHARMACEUTICALS For: May 07 | SEC filing · Form 8-K | -5.41% | -10.60% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Apr 11 | SEC filing · Form 8-K | +2.48% | -0.83% | |
| Form ARS RIGEL PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | -0.77% | -0.81% | |
| Form DEF 14A RIGEL PHARMACEUTICALS For: May 22 | SEC filing · Form DEF | -0.77% | -0.81% | |
| Form DEFA14A RIGEL PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.77% | -0.81% | |
| Form PRE 14A RIGEL PHARMACEUTICALS For: May 22 | SEC filing · Form PRE | -1.04% | -6.94% | |
| Form 10-K RIGEL PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.65% | +1.30% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Mar 05 | SEC filing · Form 8-K | +0.65% | +1.30% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Feb 22 | SEC filing · Form 8-K | -1.65% | +7.44% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Jan 08 | SEC filing · Form 8-K | +0.22% | +7.25% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Nov 27 | SEC filing · Form 8-K | -0.92% | +4.59% | |
| Form 10-Q RIGEL PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -1.52% | -1.11% | |
| Form 8-K RIGEL PHARMACEUTICALS For: Nov 07 | SEC filing · Form 8-K | -1.52% | -1.11% |
Keep exploring
More RIGL: earnings → · analyst actions → · RIGL overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GEMPHIRE THERAPEUTICS INC COMMON (GEMP) | 282 | -1.00% | 30% |
| PRINCIPIA BIOPHARMA INC COMMON (PRNB) | 282 | +0.23% | 59% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 279 | -0.52% | 36% |
| CORREVIO PHARMA CORP ORDINARY SHARES (CORV) | 279 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.